Ares Financial Consulting’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
379
+16
+4% +$16.3K 0.33% 53
2026
Q1
$347K Buy
363
+171
+89% +$173K 0.27% 57
2025
Q4
$206K Buy
+192
New +$184K 0.2% 69

Other funds holding LLY

Ares Financial Consulting's LLY Position: Q2 2026 in Review

Ares Financial Consulting increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $16.3K and bringing the position to 379 shares worth $455K. The position accounts for 0.33% of the portfolio, ranked #53.

Ares Financial Consulting first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ares Financial Consulting held 379 shares of Eli Lilly worth $455K as of Q2 2026.
  • Ares Financial Consulting bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.33% of Ares Financial Consulting's portfolio in Q2 2026, its #53 holding.
  • Ares Financial Consulting first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.